A recent population-based study showed a lack of correlation between Joint Commission indicators of elective delivery at 39 weeks’ gestation and cesarean delivery and rates of maternal and neonatal complications in deliveries at New York City hospitals in 2010.
A recent population-based study showed a lack of correlation between Joint Commission indicators of elective delivery at 39 weeks’ gestation and cesarean delivery and rates of maternal and neonatal complications in deliveries at New York City hospitals in 2010.
Led by researchers at the Icahn School of Medicine at Mount Sinai, the observational study used linked New York City discharge and birth certificate data sets from 2010. Delivery hospitalizations were identified and 2 Joint Commission obstetric quality measures (elective, nonmedically indicated deliveries at ≥37 weeks’ and < 39 weeks’ gestation; cesarean delivery performed in low-risk mothers) were assessed. Algorithms were used to identify severe maternal morbidity (delivery associated with a life-threatening complication or performance of a lifesaving procedure) and morbidity in term neonates with no anomalies (including births associated with complications like hypoxia, prolonged length of stay, and birth trauma). Mixed-effect logistic regression models, which included risk-adjustment for patient sociodemographic and clinical characteristics, were used to examine the association between neonatal and maternal morbidity and hospital-level quality measures.
Editorial: Whither the bimanual pelvic exam
Of 103,416 neonates without anomalies, 8057 experienced neonatal morbidity (7.8%), whereas severe maternal morbidity was identified in 2372 of 115,742 deliveries (2.4%). Among 41 hospitals, the rates for elective deliveries performed before the 39th week of gestation ranged from 15.5 to 41.9 per 100 deliveries. In low-risk mothers, the rates of cesarean deliveries were 11.7 to 39.3 per 100. Rates of neonatal morbidity per 100 births ranged from 3.1 to 21.3 and rates of maternal morbidity per 100 deliveries ranged from 0.9 to 5.7.
Overall, the maternal quality indicators elective delivery prior to 39 weeks’ gestation and cesarean deliveries to low-risk mothers had little association with severe maternal complications (RR, 1.00; 95% CI, 0.98-1.02 and RR, 0.99; 95% CI, 0.96-1.01, respectively) or neonatal morbidity (risk ratio [RR], 0.99; 95% confidence interval [CI], 0.97-1.01 and RR, 1.01; 95% CI, 0.99-1.03, respectively).
The investigators concluded that the 2 quality indicators examined were not associated with lower morbidity. They believe that the findings show the need for a larger number of obstetric quality measurements, such as whether protocols for hemorrhage and preeclampsia were followed in the delivery suite.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Link between reproductive life span and postmenopausal muscle mass
November 30th 2023A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Read More
How physicians can boost COVID-19 vaccine uptake among Spanish-speaking pregnant individuals
November 29th 2023Discover the crucial findings from a recent study investigating vaccine decision-making among Spanish-speaking pregnant individuals, highlighting the pivotal role doctors play in dispelling vaccine hesitancy and fostering acceptance through targeted information dissemination and culturally sensitive approaches.
Read More
NIDA study reports surge in pregnancy-associated drug overdose deaths
November 29th 2023Researchers from the National Institute on Drug Abuse unveil a 3-fold spike in drug overdose deaths among pregnant women aged 10 to 44 years between 2018 and 2021, highlighting pervasive barriers like discrimination and stigma hindering access to life-saving treatment.
Read More